Gardasil Lawsuit Worth $8 Billion Set for Jury Trial
Merck & Co. is about to face a jury trial defending against a claim that Merck advertisements misrepresented that the Gardasil vaccine was safe and effective. The jury will determine whether the drug giant hid the risks and side effects associated with its lucrative HPV (human papilloma virus) vaccine marketed to children and young adults.1 […]
Argentina Will Follow U.S. and Exit the World Health Organization
On Feb. 5, 2025, Argentina announced that it would leave the World Health Organization (WHO), following the example of the United States after President Donald Trump announced in an Executive Order (EO) on Jan. 20, 2025 that the US would exit and stop supporting the global health agency.1 Similar to the reasons that Trump cited […]
BARDA’s Big Bird Flu Vax Contract With Moderna
Last month, Moderna, Inc. slashed its revenue forecast for this year by $1 billion, prompting its stock price to plunge by more than 20 percent to $33.44. In September 2024, Moderna estimated its revenue for 2025 would be $2.5 billion to $3.5 billion, but the company revised its forecast on Jan. 13, 2025 to $1.5 […]
Baby Dies an Hour After Getting Seven Vaccines—But You Can’t Question the Shots?
Imagine taking your perfectly healthy baby to the pediatrician for a “well-baby visit.” You allow the doctor to give your baby all the scheduled vaccines and, within an hour, your healthy baby is dead. Considering that your baby was administered 7-8 vaccines—one right after the other, you naturally assume the vaccines may have had something […]
FDA Clears Investigational New Drug Application for Inhaled COVID Biologic
Biotech company Ocugen, Inc. has announced that the U.S. Food and Drug Administration (FDA) has cleared their Investigational New Drug (IND) application for a novel inhaled vaccine against SARS-CoV-2. The biologic uses novel chimpanzee adenovirus-vectored (ChAd36) technology. The approval will allow the company to initiate Phase I clinical trials for the inhaled vaccine, OCU500. The […]
EcoHealth Alliance, Dr. Daszak Sanctioned for Coronavirus Gain-of-Function Research
On Jan. 17, 2025, the U.S. House Committee on Oversight and Government Reform announced that the nonprofit EcoHealth Alliance (EHA) and its former president, Peter Daszak, PhD, have been barred from receiving funds from the U.S. Department of Health and Human Services (HHS) for five years. The sanction was imposed after evidence revealed that EcoHealth […]